Kosower N S, Glaser T, Kosower E M
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7542-6. doi: 10.1073/pnas.80.24.7542.
Rat, but not human, erythrocytes undergo fusion promoted by the membrane-mobility agent 2-(2-methoxyethoxy)-ethyl cis-8-(2-octylcyclopropyl)octanoate (A2C). The difference in behavior is correlated with rat erythrocyte membrane protein degradation caused by Ca2+-activated proteases. The human erythrocyte is deficient in such protease activity. Membrane protein degradation is a necessary, but not sufficient, requirement for membrane fusion. Membrane protein degradation probably releases membrane components from certain constraints. In addition, the motion of membrane components precedes fusion and must be promoted by reagents such as A2C, leading to the creation of fusion-potent lipid areas. This sequence of chemical and physical events occurs in other fusion processes.
大鼠红细胞(而非人类红细胞)会在膜流动性促进剂顺式 -8-(2-辛基环丙基)辛酸2-(2-甲氧基乙氧基)乙酯(A2C)的作用下发生融合。这种行为差异与由钙离子激活的蛋白酶引起的大鼠红细胞膜蛋白降解有关。人类红细胞缺乏这种蛋白酶活性。膜蛋白降解是膜融合的必要但非充分条件。膜蛋白降解可能使膜成分从某些限制中释放出来。此外,膜成分的运动先于融合,并且必须由A2C等试剂促进,从而形成具有融合能力的脂质区域。这一系列化学和物理事件也发生在其他融合过程中。